Alkem Laboratories earnings call announcements

Earnings CallAlkem Laboratories Ltd ALKEM

Alkem Laboratories Investor Presentation: Key Takeaways

Alkem reported Q1FY27 revenue of INR 3,740cr, up 11% YoY. India sales grew 10.3%, while International jumped 16%. EBITDA margin stood at 20.5%. Net profit declined 21.7% due to taxation.

Call

Guides 12% growth

Earnings CallAlkem Laboratories Ltd ALKEM

Alkem Laboratories Earnings Call: Key Takeaways

Alkem reported strong FY26 results with landmark INR 3,000cr+ EBITDA. Strategy focuses on chronic therapy growth in India and international expansion, particularly with the semaglutide launch.